MarketResearchReportStore adds "Millennium Pharmaceuticals Inc - Product Pipeline Review - 2016" latest studies, published in March 2017. It is a professional and in-depth study on the current state.

For a sample of this report, please email at: [email protected]

Description
Summary
‘Millennium Pharmaceuticals Inc - Product Pipeline Review - 2016’, provides an overview of the Millennium Pharmaceuticals Inc’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Millennium Pharmaceuticals Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from The proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Millennium Pharmaceuticals Inc
- The report provides overview of Millennium Pharmaceuticals Inc including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Millennium Pharmaceuticals Inc’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Millennium Pharmaceuticals Inc’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Request Sample Copy, please email at: [email protected]

Table Of Contents
Millennium Pharmaceuticals Inc Snapshot 5
Millennium Pharmaceuticals Inc Overview 5
Key Facts 5
Millennium Pharmaceuticals Inc - Research and Development Overview 6
Key Therapeutic Areas 6
Millennium Pharmaceuticals Inc - Pipeline Review 11
Pipeline Products by Stage of Development 11
Pipeline Products - Monotherapy 12
Pipeline Products - Out-Licensed Products 13
Out-Licensed Products/Combination Treatment Modalities 14
Millennium Pharmaceuticals Inc - Pipeline Products Glance 15
Millennium Pharmaceuticals Inc - Clinical Stage Pipeline Products 15
Phase II Products/Combination Treatment Modalities 15
Phase I Products/Combination Treatment Modalities 16
Millennium Pharmaceuticals Inc - Early Stage Pipeline Products 17
Preclinical Products/Combination Treatment Modalities 17
Discovery Products/Combination Treatment Modalities 18
Millennium Pharmaceuticals Inc - Drug Profiles 19
alisertib - Drug Profile 19
Product Description 19
Mechanism Of Action 19
R&D Progress 19
bortezomib - Drug Profile 24
Product Description 24
Mechanism Of Action 24
R&D Progress 24
orteronel - Drug Profile 31
Product Description 31
Mechanism Of Action 31
R&D Progress 31
pevonedistat hydrochloride - Drug Profile 34
Product Description 34
Mechanism Of Action 34
R&D Progress 34
sapanisertib - Drug Profile 37
Product Description 37
Mechanism Of Action 37
R&D Progress 37
serabelisib - Drug Profile 40
Product Description 40
Mechanism Of Action 40
R&D Progress 40

Browse Complete Report with TOC @
https://www.marketresearchreportstore.com/shop/millennium-pharmaceuticals-inc-product-pipeline-review-2016

For report sample or more information, please feel free to contact us:
Shirley | Sales Director
Call: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/

About Us
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best.